Transcriptional/JJ
regulation/NN
of/IN
the/DT
beta-casein/NN
gene/NN
by/IN
cytokines/NNS
:/:
cross-talk/NN
between/IN
STAT5/NN
and/CC
other/JJ
signaling/VBG
molecules/NNS
./.

The/DT
beta-casein/NN
promoter/NN
has/VBZ
been/VBN
widely/RB
used/VBN
to/TO
monitor/VB
the/DT
activation/NN
of/IN
STAT/NN
(/(
signal/NN
transducer/NN
and/CC
activator/NN
of/IN
transcription/NN
)/)
5/CD
since/IN
STAT5/NN
was/VBD
originally/RB
found/VBN
as/IN
a/DT
mediator/NN
of/IN
PRL-inducible/JJ
beta-casein/NN
expression/NN
./.
=====
However/RB
,/,
not/RB
only/RB
is/VBZ
expression/NN
of/IN
the/DT
beta-casein/NN
gene/NN
regulated/VBN
by/IN
STAT5/NN
but/CC
it/PRP
is/VBZ
also/RB
affected/VBN
by/IN
other/JJ
molecules/NNS
such/JJ
as/IN
glucocorticoid/NN
and/CC
Ras/NN
./.
=====
In/IN
this/DT
report/NN
,/,
we/PRP
describe/VBP
the/DT
transcriptional/JJ
regulation/NN
of/IN
the/DT
beta-casein/NN
gene/NN
by/IN
cytokines/NNS
in/IN
T/NN
cells/NNS
./.
=====
We/PRP
have/VBP
found/VBN
that/IN
the/DT
beta-casein/NN
gene/NN
is/VBZ
expressed/VBN
in/IN
a/DT
cytotoxic/JJ
T/NN
cell/NN
line/NN
,/,
CTLL-2/NN
,/,
in/IN
response/NN
to/TO
interleukin-2/NN
(/(
IL-2/NN
)/)
,/,
which/WDT
activates/VBZ
STAT5/NN
./.
=====
While/IN
IL-4/NN
does/VBZ
not/RB
activate/VB
STAT5/NN
,/,
it/PRP
induces/VBZ
expression/NN
of/IN
STAT5-regulated/JJ
genes/NNS
in/IN
CTLL-2/NN
,/,
i.e./FW
beta-casein/NN
,/,
a/DT
cytokine-inducible/JJ
SH2-containing/JJ
protein/NN
(/(
CIS/NN
)/)
,/,
and/CC
oncostatin/NN
M/NN
(/(
OSM/NN
)/)
,/,
suggesting/VBG
that/IN
STAT6/NN
activated/VBN
by/IN
IL-4/NN
substitutes/VBZ
for/IN
the/DT
function/NN
of/IN
STAT5/NN
in/IN
T/NN
cells/NNS
./.
=====
IL-2-induced/JJ
beta-casein/NN
expression/NN
was/VBD
enhanced/VBN
by/IN
dexamethasone/NN
,/,
and/CC
this/DT
synergistic/JJ
effect/NN
of/IN
Dexamethasone/NN
requires/VBZ
the/DT
sequence/NN
between/IN
-155/CD
and/CC
-193/CD
in/IN
the/DT
beta-casein/NN
promoter/NN
./.
=====
Coincidentally/RB
,/,
a/DT
deletion/NN
of/IN
this/DT
region/NN
enhanced/VBD
the/DT
IL-2-induced/JJ
expression/NN
of/IN
beta-casein/NN
./.
=====
Expression/NN
of/IN
an/DT
active/JJ
form/NN
of/IN
Ras/NN
,/,
Ras(G12V)/NN
,/,
suppressed/VBD
the/DT
IL-2-induced/JJ
beta-casein/NN
and/CC
OSM/NN
gene/NN
expression/NN
,/,
and/CC
the/DT
negative/JJ
effect/NN
of/IN
Ras/NN
is/VBZ
mediated/VBN
by/IN
the/DT
region/NN
between/IN
-105/CD
and/CC
-193/CD
in/IN
the/DT
beta-casein/NN
promoter/NN
./.
=====
In/IN
apparent/JJ
contradiction/NN
,/,
expression/NN
of/IN
a/DT
dominant/JJ
negative/JJ
form/NN
of/IN
Ras/NN
,/,
RasN17/NN
,/,
also/RB
inhibited/VBD
IL-2-induced/JJ
activation/NN
of/IN
the/DT
promoter/NN
containing/VBG
the/DT
minimal/JJ
beta-casein/NN
STAT5/NN
element/NN
as/RB
well/RB
as/IN
the/DT
promoters/NNS
of/IN
CIS/NN
and/CC
OSM/NN
./.
=====
In/IN
addition/NN
,/,
Ras(G12V)/NN
complemented/VBD
signaling/NN
by/IN
an/DT
erythropoietin/NN
receptor/NN
mutant/NN
defective/JJ
in/IN
Ras/NN
activation/NN
and/CC
augmented/VBD
the/DT
activation/NN
of/IN
the/DT
beta-casein/NN
promoter/NN
by/IN
the/DT
mutant/JJ
erythropoietin/NN
receptor/NN
signaling/NN
,/,
suggesting/VBG
a/DT
possible/JJ
role/NN
of/IN
Ras/NN
in/IN
Stat5-mediated/JJ
gene/NN
expression/NN
./.
=====
These/DT
results/NNS
collectively/RB
reveal/VBP
a/DT
complex/JJ
interaction/NN
of/IN
STAT5/NN
with/IN
other/JJ
signaling/NN
pathways/NNS
and/CC
illustrate/VBP
that/IN
regulation/NN
of/IN
gene/NN
expression/NN
requires/VBZ
integration/NN
of/IN
opposing/JJ
signals/NNS